Relay Therapeutics, Inc.RLAYNASDAQ

Revenue (LTM)

$15M

+53.4% YoY

Net Income (LTM)

$-276M

+18.1% YoY

Free Cash Flow

$-236M

Revenue CAGR (5Y)

-28.6%

Marginsdeclining

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	3	1↓54.4%	26↑1749.8%	10↓60.8%	15↑53.4%
Gross Profit	3	1↓54.4%	26↑1749.8%	10↓60.8%	12↑17.9%
Operating Income	-365	-299↑17.9%	-373↓24.6%	-372↑0.1%	-303↑18.7%
Net Income	-364	-291↑20.2%	-342↓17.7%	-338↑1.2%	-276↑18.1%
EBITDA	-223	-307↓37.5%	-374↓21.9%	-380↓1.6%	-273↑28.2%
EPS Diluted	-3.82	-2.59↑32.2%	-2.79↓7.7%	-2.36↑15.4%	-1.61↑31.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	280	999↑256.6%	144↓85.6%	124↓13.5%	84↓32.4%
Total Current Assets	976	1,020↑4.4%	770↓24.5%	809↑5.1%	578↓28.5%
Total Assets	1,008	1,100↑9.1%	844↓23.3%	871↑3.2%	621↓28.7%
Total Current Liabilities	24	64↑162.0%	30↓52.5%	51↑67.6%	26↓49.6%
Total Liabilities	111	150↑35.2%	92↓38.5%	94↑1.7%	54↓42.0%
Total Equity	898	950↑5.8%	752↓20.9%	778↑3.4%	567↓27.1%
Total Debt	23	58↑152.1%	53↓7.4%	49↓9.3%	32↓33.1%
Net Debt	-257	-941↓265.9%	-90↑90.4%	-76↑16.0%	-52↑32.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-74	-229↓208.4%	-300↓30.9%	-249↑17.1%	-235↑5.5%
Capital Expenditure	-3	-9↓161.1%	-4↑54.5%	-2↑51.1%	-0↑79.7%
Free Cash Flow	-78	-239↓206.3%	-304↓27.6%	-251↑17.5%	-236↑6.1%
Stock-Based Comp	48	56↑15.9%	86↑53.2%	94↑9.4%	62↓33.7%
Net Change in Cash	-166	-128↑22.6%	-8↑93.8%	-20↓152.7%	-41↓104.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance